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Abstract
Lipids play an important role in many neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s
disease, and Huntington’s disease. Zebrafish models for these diseases have been recently developed. The
detailed brain lipid composition of the adult zebrafish is not known, and therefore, the representativeness of
these models cannot be properly evaluated. In this study, we characterized the total lipid composition of healthy
adult zebrafish using 1H nuclear magnetic resonance spectroscopy. A close resemblance of the zebrafish brain
composition is shown in comparison to the human brain. Moreover, several lipids involved in the pathogenesis
of neurodegenerative diseases (i.e., cholesterol, phosphatidylcholine, docosahexaenoic acid, and further,
polyunsaturated fatty acids) are detected and quantified. These lipids might represent useful biomarkers in
future research toward human therapies. Matrix-assisted laser desorption–ionization time-of-flight mass spec-
trometry coupled with high-performance thin-layer chromatography was used for further characterization of
zebrafish brain lipids. Our results show that the lipid composition of the zebrafish brain is rather similar to the
human brain and thus confirms that zebrafish represents a good model for studying various brain diseases.
Introduction
In recent years, transgenic zebrafish models have beendeveloped for several neurodegenerative diseases, such as
Huntington’s disease (HD),1 Parkinson’s disease (PD),2–4
and Alzheimer’s disease (AD).5,6 The availability of several
mutants for these diseases results from the fact that zebrafish
have a similar brain organization to that of human brains.5
Brain regions that are affected in neurodegenerative diseases
in humans show similar cell type content in zebrafish brains.7
Moreover, the presence of a dopaminergic system, glia and
astrocytes, and the existence of ortholog genes for PD, AD,
and HD increase the usefulness of zebrafish as a model for
these diseases.7 In general, the advantages of using the
zebrafish model system for research are the relatively low
cost of housing and maintenance, the fast reproduction, the
transparency and size of the larvae, and the ability to house
the larvae in a 96-well plate, which open up the unique op-
portunity to perform affordable in vivo high-throughput drug
screening.1,7
Polar metabolites in the zebrafish brain have recently been
characterized and show high similarities with the composi-
tion of the human brain.8 However, brain lipids of the zebra-
fish have not yet been investigated at all. The importance of
these lipids is evident, since they are involved in multiple
underlying mechanisms in the pathogenesis of neurodegen-
erative diseases, which were comprehensively reviewed in
recent literature. For example, in AD, an altered membrane
lipid metabolism has been observed, which was linked to
the oxidative stress of the plaque forming amyloid b-peptide
that raises ceramide and cholesterol levels.9,10 In addition,
membrane damage occurs due to fragmentation and lipid
peroxidation of membrane phospholipids (PLs). As a con-
sequence, fragmented polyunsaturated fatty acyl residues of
the most abundant of these lipids, phosphatidylcholine (PC),
can activate the platelet activating factor receptor and cause
inflammation.11,12 Several lipid molecules associated with li-
pid peroxidation have also been found to be raised in patients
with PD.13 An important factor in the pathogenesis of PD
is oxidative stress caused by free radicals or more generally
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reactive oxygen species.14 Moreover, raised levels of poly-
unsaturated fatty acids (PUFA) in the brain, such as doc-
osahexaenoic acid (DHA), were recently found to stimulate
the oligomerization of a-synuclein, the protein that forms ag-
gregates in the nerve cells of PD.14 Finally, several mutations
in lipid regulating proteins could be a cause of susceptibility
for developing PD.15 In addition, in brains of patients with HD,
the cholesterol biosynthetic pathway has been impaired in the
brain due to decreased translocation of binding proteins to the
nucleus.16
Thus, brain lipids play a vital role in the pathology and
progression of neurodegenerative diseases. These lipids, such
as cholesterol, PC, DHA, and other PUFAs, have been rec-
ognized as potential biomarkers for brain disease and/or
targets for future therapy.10,16–18 Therefore, it is very im-
portant to know the precise lipid composition of the zebrafish
brain and whether the lipid composition is similar to the
human brain. The representativeness of the above-mentioned
models can then be evaluated with regard to future research
toward human applications. 1H nuclear magnetic resonance
(NMR) represents a useful method to characterize lipid
compositions of tissues. It has been applied successfully to
the characterization19,20 and quantification21 of fish oil con-
tents, particularly, the fatty acyl composition. In addition,
polar metabolite characterization in zebrafish brain has been
previously performed using 1D and 2D 1H NMR.8
In the present study, we characterize zebrafish brain lipids
using 1D and 2D 1H NMR spectroscopy and matrix-assisted
laser desorption–ionization time-of-flight mass spectrometry
(MALDI-TOF-MS) coupled with high-performance thin-
layer chromatography (HPTLC). Although an in-depth
characterization could not be achieved due to the high com-
plexity, our results show that the lipid composition of the
zebrafish brain is very similar to the human brain.22 In ad-
dition, potential lipid biomarkers of various neurodegenera-
tive diseases, that is, DHA, PC, cholesterol, and PUFAs such
as linoleic acid (LA) and a-linolenic acid (ALA), were de-
tected and quantified. Human brain levels of cholesterol,
DHA, and PC were compared to the zebrafish brain.
Materials and Methods
Animals
Adult wild-type zebrafish (Danio rerio) were maintained
according to established rearing procedures, in recirculating
aquarium systems.23 The water temperature was maintained
at 28C with a flow rate of 150 L/min, with 12-h day/12-h
night light cycles. The fish were fed twice a day with com-
mercial flake food according to Westerfield.23 All fish were
handled according to the Institutional Animal Care and Use
Committee guidelines.
Tissue preparation and extraction
Zebrafish were euthanized, their brains were carefully re-
moved from the skull, and immediately frozen in liquid ni-
trogen. For the extraction of brain lipids from zebrafish, a
modified procedure of Suhartono et al. was used.24 The
brains from 10 zebrafish (*70 mg fresh weight) were crushed
in 1 mL of methanol:water (1:1, v/v) mixture. Subsequently,
1 mL of chloroform was added. The mixture was then soni-
cated for 15 min and centrifuged at 5000 rpm at 4C. After
centrifugation, the two layers (lower chloroform layer and
upper methanol:water layer) were carefully separated and
each was dried individually under nitrogen gas flow at 4C.
The dried chloroform layer containing the lipids was dis-
solved in 1 mL deuterated chloroform and subsequently fil-
tered using a Millipore filter (Millex-HV 0.45-lm Filter Unit).
Tetramethylsilane (TMS, 0.03%) was used as a reference.
NMR spectroscopy
The NMR spectra were recorded at room temperature with
a Bruker 600 MHz DMX NMR spectrometer using a 5-mm
inverse triple high-resolution probe with an actively shielded
gradient coil. The 1H NMR spectra were accumulated with
65,000 data points, a 2-s relaxation delay, and a sweep width
of 12.4 kHz; 128 scans were required to obtain a satisfactory
signal-to-noise ratio. The free induction decays were weighted
with an exponential function (0.09 Hz) before Fourier trans-
formation. Two-dimensional homonuclear 1H-1H experiments
were performed using the chemical shift correlated spectro-
scopic (COSY) sequence. The chemical shifts are relative
to TMS.
Data analysis
NMR data analysis was performed using MestReNova
software version 6.0.3-5604 (Mestrelab Research S.L., San-
tiago de Compostela, Spain). The concentrations of the var-
ious lipids in the brain extract were determined by comparing
the integral peak intensity of the compounds of interest with
that of the TMS peak, after correcting for the number of
contributing protons and for tissue weight. Quantification of
cholesterol and PC was made through the characteristic NMR
signal as follows: for cholesterols (i.e., free cholesterol and
cholesterol esters) at 0.7 ppm (C18-CH3); for PC at 3.3 ppm
(-N + -(CH3)3). Deconvolution was performed by applying a
fit region to the 0.85–0.95 ppm range of the spectrum and
fitting the peaks one by one to be able to calculate the areas of
the individual resonances.
High-performance thin-layer chromatography
The organic brain extract was subjected to HPTLC before
MALDI-TOF-MS as described previously.25 Samples were
applied on to HPTLC silica gel 60 plates (10 · 10 cm2 with
aluminum backs; Merck, Darmstadt, Germany) and devel-
oped in vertical TLC chambers using CHCl3–ethanol–water–
triethylamine (35/35/7/35, v/v/v/v) as the mobile phase for
the separation of PLs. Lipids were visualized by spraying
with a solution of primuline.26 Upon excitation by ultraviolet
light (366 nm), individual lipids become detectable as col-
ored spots. These spots were assessed by using a digital im-
age system in combination with the program Argus · 1
delivered by BioStep ( Jahnsdorf, Germany).
Coupling of HPTLC with MALDI-TOF-MS
The TLC plates for MS analysis were cut into smaller pieces
containing all relevant lipid spots. These pieces were mounted
to a prototype MALDI-TOF-MS adapter target27 with double-
sided, conductive adhesive tape (Leit Tabs; Plano GmbH,
Wetzlar, Germany). All MALDI spectra of TLC-separated
lipids shown in this article were directly obtained from the
HPTLC plates, and this approach was described in more detail


























































earlier.27 The matrix addition [a 100-mg/mL solution of 2,5-
dihydroxybenzoic acid (DHB) in acetonitrile–water (1/1, v/v)]
was performed manually on circled spots monitored by pre-
vious primuline staining. Selected negative ion mass spectra
were recorded in the presence of 9-aminoacridine as recently
described.28
MALDI-TOF mass spectrometry
All MALDI-TOF mass spectra were acquired using an
Autoflex I mass spectrometer (Bruker Daltonics, Billerica,
MA) with ion reflector, as described earlier.25 The system
utilizes a pulsed 50 Hz nitrogen laser emitting at 337 nm. The
extraction voltage was 20 kV, and gated matrix suppression
was applied to prevent the saturation of the detector by matrix
ions. All spectra were acquired in the reflector mode using
delayed extraction. Spectral mass resolutions and signal-to-
noise ratios were determined by the instrument software Flex
Analysis 2.4 (Bruker Daltonics). The mass spectrometer was
calibrated using the molecular ions of a lipid mixture des-
orbed from a standard DHB preparation applied next to the
spots of interest. Selected measurements were also performed
with DHB saturated with CsCl. This minimizes the interfer-
ences between different adducts (H + and Na + ) and differ-
ences in the fatty acyl compositions of the lipids. This
procedure is essentially described in Schiller et al.29 In se-
lected cases, postsource decay (PSD) spectra were also re-
corded to confirm either the headgroup of the corresponding
lipid (positive ion mode) or the fatty acyl compositions
(negative ion mode).30
Result and Discussion
Brain lipids are involved in the pathogenesis of neurode-
generative diseases.9–16 To characterize the zebrafish brain
lipids and assess its similarity to the human brain, we ana-
lyzed the total lipid fraction of normal adult zebrafish brain
using 1H NMR and MALDI-TOF-MS. Figure 1 shows the
representative 1H NMR spectrum of the total lipid extracts
prepared from normal zebrafish brain. The main lipid signals
detected in zebrafish brains are from cholesterol (Chol), the
glycerol, and the headgroup of PLs and their fatty acyl resi-
dues. The complete assignment of the resonances detectable
in the spectrum in Figure 1 is shown in Table 1. The as-
signment of the zebrafish brain lipid resonances was aided by
comparing our spectrum with previous 1H NMR studies using
isolated, relevant compounds31 or with fish (oil),19,20 which is
a rich source of (highly unsaturated) lipids. A comparison of
the lipid composition of the zebrafish brain with that of hu-
man brain is also shown in Table 1. The overall peak patterns
of the lipids in the zebrafish and human brain appear very
similar. However, some of the peaks, for example, at che-
mical shifts 0.880, 0.973, 1.653, 2.075, and 2.370 ppm in the
zebrafish brain, were not observed in a previous study of the
human brain.22 Figure 2 shows a 2D homonuclear (1H-1H)
dipolar correlation NMR spectrum of the total lipid extract of
the normal zebrafish brain. On the basis of the cross peaks, a
clear assignment of several brain lipids was obtained. The
signals at 0.859 and 0.870 ppm were assigned to the terminal
CH3 groups of cholesterol and at 0.915 ppm to the proton at
the C21 of cholesterol. The 2D NMR spectrum also confirms
the presence of resonances that were not seen in the human
brain (Fig. 2; Table 1). An explanation for this difference may
be attributed to the prevalence of unsaturated fatty acyl res-
idues in the zebrafish brain as compared to the human brain.
According to Tocher et al.,32,33 the most prevalent PUFAs in
freshwater fish, such as the zebrafish, are x-3 fatty acids such
as ALA and x-6 fatty acids such as LA. Both are taken up
from nutritional lipids and are, therefore, named essential
fatty acids (EFAs).34 Freshwater fish can convert these EFAs
to form highly unsaturated fatty acids (UFAs), such as the
x-3 fatty acids, eicosapentanoic acid, and DHA.23 Humans
can synthesize these fatty acids only in small amounts,35 so
dietary intake is needed. The signal at 0.880 ppm, not seen in
the human brain, was assigned to the terminal CH3 group of
an x-6 fatty acid, most likely LA. Another peak that was not
found in the human brain spectrum is the triplet at 0.973 ppm,
which can be assigned to the terminal CH3 of an x-3 FA,
probably ALA. The clear separation of the x-3 and x-6 fatty
acid methyl resonances can be explained by the fact that the
protons of the terminal CH3 group of x-3 fatty acids are close
to a double bond. This results in a downfield chemical shift of
the signal of the methyl group of non-x-3 fatty acids that can
be used for quantification.21 The DHA signals are well sep-
arated from non-DHA fatty acids. In DHA, C2 and C3 meth-
ylene (C2,3-CH2) are interposed between the carboxyl group at
C1 and the double bond at C4. Because of this electronegative
environment ( - I effect), the C2,3 methylene groups of DHA
result in resonances in an isolated downfield region (between
2.32 and 2.42 ppm), well separated from the signals of similar
methylene protons of non-DHA fatty acids (2.28 and 2.37 ppm)
(Table 1).21,36
Surprisingly, a DHA-specific resonance was not reported
in the human brain in a previous NMR study,22 although
DHA is one of the most abundant fatty acids in the human
brain.37 A possible explanation for this discrepancy could be
that the brain biopsies that were used to characterize normal
human brain lipids were isolated from the tissue surrounding
the brain tumor.22 The investigated tumors mostly reside in
the white matter and meninges, while DHA is predominantly
found in the gray matter.38 Therefore, the reason why DHA
was not detected in the human brain, but was seen in zebrafish
FIG. 1. The 1H nuclear magnetic resonance (NMR) spec-
trum of the total lipid extract from normal adult zebrafish
brain. The 1H chemical shifts were determined relative to
tetramethylsilane (at 0.00 ppm) as reference. The assignments
of the peak numbers are shown in Table 1.


























































brain, could be caused by sampling differences rather than its
actual absence.
For both the human and zebrafish brain, FA signals with
some overlaps with cholesterol signals are observed at 1.25/
1.27 and 5.36/5.35 ppm, indicating that further unsaturated
fatty acids are detectable in the human tissue.22 One of the
candidates could be oleic acid, the main constituent of
myelin, which in turn is the main constituent of the white
matter.39 The human brain signal at 3.63 ppm remained un-
assigned by Tugnoli et al.22 Whereas this signal does not
show up in our spectra, it was seen in an older zebrafish brain
lipid sample (data not shown). Two-dimensional COSY
NMR of this old lipid fraction from zebrafish brain revealed
similarities to cholesterol and FAs (data not shown), indi-
cating a possible breakdown (oxidation) product of these
compounds. The remaining two signals that are only seen in
zebrafish brain, at chemical shifts 1.653 and 2.075 ppm, were
assigned to parts of x-3 fatty acids (Table 1).
Since PLs are major constituents of the brain,40 MALDI-
TOF-MS coupled with HPTLC was used for further charac-
terization of the zebrafish brain PLs. Figure 3A shows the
thin-layer chromatograms of a reference mixture of different,
known PLs (Fig. 3-a) and the zebrafish lipid brain extract
(Fig. 3-b). A good separation quality of the individual PLs is
evident and PC was found to be the most prominent PL in
Table 1. 1H NMR Chemical Shift Assignments of Lipid in Deuterated Chloroform (CDCl3)
Extracted from Zebrafish Brain
a
and from Normal Human Brain
b
Zebrafisha Humanb
Chemical shift (ppm) Chemical shift (ppm)
Peak no. Assignments Measured at 600 MHz 250 MHz
1 Chol (C18) s 0.67 0.67
2 Chol (C26,27) dd 0.85, 0.87 0.83, 0.85
3 x-6 FA -CH3 (terminal) t 0.88 –
4 Chol (C21) d 0.91 0.89
5 x-3 FA -CH3 (terminal) t 0.97 –
6 Chol (C19) s 1.00 0.99
7 Chol m 1.11 1.10
8 Chol + FA (CH2) s 1.25 1.27
9 Chol + FA (CH2) m 1.52 1.50
10 FA (CH2) bs 1.65 –
11 Chol + FA (CH2) d 1.83 1.80
12 FA (CH2)–Chol m 2.00 2.00
13 FA (CH2) quin 2.07 –
14 FA (CH2)–Chol m 2.28 2.27
15 FA (CH2)–DHA m 2.37 –
16 FA (CH2)–PUFA dd 2.82 2.80
17 PLs bs 3.15 3.20
18 PC s 3.34 3.30
19 Chol (C3) m 3.52 3.53
U Unassigned bs – 3.63
20 Phosphotidylglycerol bm 4.08 4.18
21 Sphingolipids m 5.22 5.20
Dolichols
Plasmalogens
22 FA (-CH = CH-) and Chol m 5.36 5.35
23 CDCl3 s 7.26 7.25
aThis study.
bAdapted from Tugnoli et al.22
s, singlet; d, doublet; t, triplet; m, multiplet; quin, quintet; dd, double doublet; bs, broad singlet; bm, broad multiplet; Chol, cholesterol;
DHA, docosahexaenoic acid; FA, fatty acids; PC, phosphatidylcholine, PLs, phospholipids; PUFA, polyunsaturated fatty acid; NMR,
nuclear magnetic resonance.
FIG. 2. High-resolution 2D 1H-1H homonuclear correla-
tion spectrum of the total lipid extract from normal adult
zebrafish brain.


























































the zebrafish brain. Spots corresponding to (galactosyl)-
cerebrosides and cholesterol are also clearly detectable and
assigned in Figure 3A. Please note that different mass spectra
can be obtained in dependence on the position where the laser
beam hits the spot on the TLC plate. This is explained by the
inhomogeneous distribution of the lipids in dependence on
their fatty acyl composition. This effect is more pronounced
the higher the Rf value and is thus exemplarily shown for the
(galactosyl)-cerebroside fraction.27 Moderate differences in
the migration properties (Rf values) of lipids in the zebrafish
brain extract in comparison to the lipid standard are obvious,
but these are caused by differences in the fatty acyl compo-
sitions of the individual lipids: it is well known that the dis-
tribution of the lipids within a given spot is not homogeneous,
but depends on the fatty acyl composition and particularly the
chain length.26 These differences can be easily resolved by
subsequent mass spectrometric analysis. The positive ion
MALDI-TOF mass spectra of some selected brain lipid
fractions (obtained directly from the developed TLC plate)
are shown in Figure 3B and the assignments of all detected
major peaks are provided in Table 2. Both the H + and Na +
adducts were clearly observed in the spectrum of individual
PLs, whereby the protons are stemming from the carboxylic
group of the used matrix, while sodium ions are omnipresent
in all biological samples. Furthermore, methodological de-
tails are available in Fuchs.41 There are interferences between
the individual adducts and differences in the fatty acyl
compositions: for instance, a PC peak at m/z 782.6 might be
caused either by the Na + adduct of PC 16:0/18:1 or the H +
adduct of PC 16:0/20:4. Therefore, all ambiguous peak as-
signments were confirmed by repeating the measurement
with CsCl-saturated matrix since this approach enables un-
equivocal assignments.29 The representative spectra of PC
and phosphatidylethanolamine (PE) fractions measured with
the CsCl-saturated matrix and the corresponding assign-
ments are shown in Supplementary Figure S1 (Supplemen-
tary Data are available online at www.liebertpub.com/zeb).
FIG. 3. (A) Image of a high-performance
thin-layer chromatography (HPTLC) plate
of a reference PL mixture (1.69 mg each) (a)
and the zebrafish lipid brain extract (b)
subsequent to primuline staining. Rf values
of cerebrosides are very similar to the Rf
value of the PG as described previously.40
(B) Positive ion matrix-assisted laser desorption–
ionization time-of-flight (MALDI-TOF)
mass spectra of the individual PL fractions
of the zebrafish brain extract recorded di-
rectly after HPTLC separation. Even rather
pale spots (e.g., the PI spot in A) gave high-
quality MALDI mass spectra. All peaks are
marked according to their m/z ratio. For
detailed peak assignments, refer to Table 2.
SM, sphingomyelin; PC, phosphatidylcholine;
PI, phosphatidylinositol; PE, phosphatidyleth-
anolamine; (Gal)-Cer, (Galacto)-cerebrosides;
PG, phosphatidylglycerol; PL, phospholipid.
Unknown impurities in selected lipid frac-
tions are marked by asterisks (*). The as-
signment of the glycolipids was made with
reference to a previous article.40
Table 2. Survey of the Most Intense Peaks
Detected in the Positive Ion MALDI-TOF Mass
Spectra of the Zebrafish Brain Lipid Extract
and the Corresponding Assignments
a,b
Peak position
(m/z) Assignment of molecular mass
502.3 LPE 18:1 (+ Na+ )
524.3 LPE 18:1 ( - H + + 2Na+ )
551.0 Oligomerization product of DHB matrix
725.5 SM 16:0 (+ Na+ )
734.6 PC 16:0/16:0 (+ H + )
740.5 PE 16:0/18:1 (+ Na+ )
753.5 SM 18:0 (+ Na+ )
756.6 PC 16:0/16:0 (+ Na+ )
760.6 PC 16:0/18:1 (+ H + )
782.6 PC 16:0/18:1 (+ Na+ )
786.5 PE 16:0/22:6 (+ Na+ )
788.6 PC 18:0/18:1 (+ H + )
806.6 PC 16:0/22:6 (+ H + )
808.5 PE 16:0/22:6 ( - H + + 2Na+ )
810.6 PC 18:0/18:1 (+ Na+ )
814.5 PE 18:0/22:6 (+ H + )
822.7 Gal-Cer 24:1/18:1 (+ Na+ )
828.6 PC 16:0/22:6 (+ Na+ )
835.6 SM 24:1 (+ Na+ )
836.5 PE 18:0/22:6 ( - H + + 2Na+ )
850.7 Hydroxylated Gal-Cer 24:1/18:1 (+ Na+ )
909.6 PI 18:0/20:4 (+ H + )
931.6 PI 18:0/20:4 (+ Na+ )
Spectra were recorded subsequent to separation by HPTLC.
aAll PL besides SM and PC contain functional groups showing
exchange with the solvents and/or ions of the matrix solution
leading to complex peak patterns.
bMost of the lipid assignments are based on Fuchs et al.40
Gal-Cer, Galacto-cerebrosides; LPE, lysophosphatidylethanolamine;
PE, phosphatidylethanolamine; PI, phosphatidylinositol; SM, sphingo-
myelin; HPTLC, high-performance thin-layer chromatography;
MALDI-TOF, matrix-assisted laser desorption–ionization time-of-
flight.


























































Docosahexaenoyl residues are clearly detectable in the PC
fraction at m/z 806.6 and 828.6 (PC 16:0/22:6) as well as in
the PE fraction at m/z 814.5 and 836.5 (PE 18:0/22:6) (Fig.
3B). Docosapentaenoyl residues (22:5) are also clearly visi-
ble in the PC fraction at m/z 808.6 and 830.6 (PC 16:0/22:5),
while 22:5 is not detectable in the PE fraction. Information
about the fatty acyl residues within the selected PE and PI
fractions has been additionally confirmed by negative ion
MALDI-TOF mass spectra in conjunction with PSD capa-
bility of MALDI-MS (Supplementary Fig. S2). The identi-
fication of these fatty acyl residues by MS confirms the
results obtained by 1H NMR. A more detailed discussion of
all other detectable lipid species was beyond the scope of this
article. However, further methodological details are available
in Fuchs.41
Our results show that lipids that have been proposed in
previous studies to be potential biomarkers for neurodegen-
erative diseases can be detected in zebrafish brain.10,16–18
These species include (i) cholesterol, which increases in AD
and HD; (ii) PC, which decreases in AD; and (iii) DHA/
PUFAs, which are raised in PD and suggested to promote the
formation of highly soluble oligomers with a-synuclein that
precede the insoluble a-synuclein aggregates associated with
neurodegeneration. In the 1H NMR spectrum, almost none of
the signals of these lipids overlapped with other lipid peaks,
except for the peaks in the 0.85–0.95 ppm range. In this study,
the signal for the terminal CH3 of x-3 overlaps with the
cholesterol resonance, which makes quantification more
difficult. However, by performing line fitting analysis or
deconvolution, peaks could be separated and integrated. The
concentrations and amounts of the above-mentioned poten-
tial lipid biomarkers were quantified in normal adult zebra-
fish brain and are shown in Table 3. Table 4 shows the
reported concentrations and the amounts of cholesterol,
DHA, and PC in human brain. Cholesterol concentration in
the adult human brain is reported to be 23 mg/g.42 However,
Igarashi et al. found cholesterol amounts of 45 – 13.9 lmol/g
(equal to about 17.4 mg/g) in human brain.43 The reported
amount of DHA in the adult human brain is about 5 g,44
which results in 3.7 mg/g, when the average adult human
brain weight of 1350 g is considered. Igarashi et al.43 reported
a DHA concentration in the human brain cortex of 10.23 –
1.8 lmol/g. The amount of PC in human brain white matter is
*9.37 mg/g and in gray matter *8.01 mg/g.45 The concen-
trations of LA and ALA in the human brain have not been
reported so far.
Upon comparing Tables 3 and 4, it is clear that the relative
cholesterol concentration is about two times higher in the
human brain, while the relative DHA and PC levels are ap-
proximately two times lower when compared to the zebrafish
brain. Although quantitative differences in lipids between
humans and zebrafish brains are seen, all types of lipids,
which could be important for future human therapies (such as
glycolipids), are also present in the zebrafish brain. When
differences in lipid concentrations and amounts are taken into
account properly, the zebrafish brain may serve as a valid
model for several lipid-related brain diseases, including
neurodegenerative diseases.
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